AR121148A1 - DEOPTIMIZED SARS-CoV-2 AND METHODS AND USES OF THE SAME - Google Patents

DEOPTIMIZED SARS-CoV-2 AND METHODS AND USES OF THE SAME

Info

Publication number
AR121148A1
AR121148A1 ARP210100197A ARP210100197A AR121148A1 AR 121148 A1 AR121148 A1 AR 121148A1 AR P210100197 A ARP210100197 A AR P210100197A AR P210100197 A ARP210100197 A AR P210100197A AR 121148 A1 AR121148 A1 AR 121148A1
Authority
AR
Argentina
Prior art keywords
cov
sars
deoptimized
methods
same
Prior art date
Application number
ARP210100197A
Other languages
Spanish (es)
Inventor
Chen Yang
Steffen Mueller
John Robert Coleman
Ying Wang
Original Assignee
Codagenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codagenix Inc filed Critical Codagenix Inc
Publication of AR121148A1 publication Critical patent/AR121148A1/en

Links

Abstract

Se proveen coronavirus SARS-CoV-2 modificados. Estos virus han sido recodificados, por ejemplo, mediante desoptimización de codones o desoptimización del sesgo de pares de codones y son de utilidad para reducir la probabilidad o severidad de una infección por coronavirus SARS-CoV-2, para prevenir una infección por coronavirus SARS-CoV-2, para generar una respuesta inmunológica o para tratar una infección por coronavirus SARS-CoV-2.Modified SARS-CoV-2 coronaviruses are provided. These viruses have been recoded, for example, by codon deoptimization or codon pair bias deoptimization and are useful in reducing the probability or severity of a SARS-CoV-2 coronavirus infection, in preventing a SARS-CoV-2 coronavirus infection. CoV-2, to generate an immune response or to treat a SARS-CoV-2 coronavirus infection.

ARP210100197A 2020-01-28 2021-01-27 DEOPTIMIZED SARS-CoV-2 AND METHODS AND USES OF THE SAME AR121148A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202062966750P 2020-01-28 2020-01-28

Publications (1)

Publication Number Publication Date
AR121148A1 true AR121148A1 (en) 2022-04-20

Family

ID=81345139

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210100197A AR121148A1 (en) 2020-01-28 2021-01-27 DEOPTIMIZED SARS-CoV-2 AND METHODS AND USES OF THE SAME

Country Status (1)

Country Link
AR (1) AR121148A1 (en)

Similar Documents

Publication Publication Date Title
CO2022010743A2 (en) Sars-cov-2 deoptimized and methods and uses thereof
UY37961A (en) NEW AND HIGHLY ACTIVE INDOLO-2-CARBOXAMIDS REPLACED WITH PIRAZOLO-PYRIMIDINE ACTIVE AGAINST HEPATITIS B (VHB) VIRUSES
CL2018001207A1 (en) Compound of 7- (thiazol-5-yl) pyrrolopyrimidine as a tlr7 agonist
EA202193251A1 (en) PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS
EA201792429A1 (en) Derivatives of mono-or dislocated indo as an inhibitor of dengue virus replication
UY35266A (en) ANTIVIRAL COMPOUNDS
UY37962A (en) NEW AND HIGHLY ACTIVE INDOL-2-CARBOXAMIDS REPLACED WITH AMINO-TIAZOL ACTIVE AGAINST THE HEPATITIS B (VHB) VIRUSES
ECSP077252A (en) Methods to treat hepatitis C
BR112022000503A2 (en) Compounds Useful for Treating Influenza Virus Infections
EA201992329A1 (en) SUBSTITUTED INDOLINE DERIVATIVES AS MONEY VIRUS REPLICATION INHIBITORS
UY34983A (en) EFFECTIVE ANTIVIRAL COMPOUNDS TO INHIBIT THE REPLICATION OF HEPATITIS C ("HCV") VIRUSES AND C RELATED OMPOSITIONS
UY32715A (en) USEFUL PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF HEPATITIS C (HCV) VIRUSES, USES AND RELATED METHODS
EA201992334A1 (en) SUBSTITUTED INDOLINE DERIVATIVES AS MONEY VIRUS REPLICATION INHIBITORS
EA201992782A1 (en) SUBSTITUTED INDOLINE DERIVATIVES AS MONEY VIRUS REPLICATION INHIBITORS
CL2015001971A1 (en) Tetracyclic compounds substituted with heterocycle and methods of use thereof for the treatment of viral diseases.
UY36903A (en) DERIVATIVES OF INDOL MONO- OR DISABLED AS INHIBITORS OF THE VIRAL REPLICATION OF DENGUE
UY32720A (en) PHARMACEUTICAL COMBINATIONS USEFUL FOR THE TREATMENT OF HEPATITIS C (HCV) VIRUSES, USES AND RELATED METHODS
UY32721A (en) USEFUL PHARMACEUTICAL COMPOSITIONS TO TREAT HEPATITIS C (HCV) VIRUSES, USES AND RELATED METHODS
EA202190854A1 (en) HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS
BR112021025655A2 (en) Human immunodeficiency virus replication inhibitors
CL2017003309A1 (en) Methods of purification and / or viral inactivation
AR121148A1 (en) DEOPTIMIZED SARS-CoV-2 AND METHODS AND USES OF THE SAME
EA201891555A1 (en) VACUS VIRUS FROM REPRODUCTIVE AND RESPIRATORY SYNDROME OF PIGS
BR112022018945A2 (en) TECHNOLOGIES TO PREVENT OR TREAT INFECTIONS
ES2054759T3 (en) PROCEDURE FOR OBTAINING INDUCTORS FROM PARAINMUNITY.